advisorsecurities master

VORVor Biopharma Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
23430
Ticker
VOR
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-02-05
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
VOR

Detail

Enriched 2026-08-14 20:47

Market cap
$1,321,685,647.96
Shares outstanding (class)
54,185,877
Shares outstanding (weighted)
59,162,294
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
76
Location
BOSTON, MA
Description

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data